Skip to main content
Clinical Trials/NL-OMON46683
NL-OMON46683
Completed
Not Applicable

A pilot study exploring the reproducibility and suitability for multi-center clinical trials of fMRI bold signal during a monetary incentive delay task and arterial spin labeling with and without prior administration of Risperidone - Site Evaluation Pilot Study

Millennium Pharmaceuticals, Inc. A Takeda Oncology Company0 sites5 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Millennium Pharmaceuticals, Inc. A Takeda Oncology Company
Enrollment
5
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Millennium Pharmaceuticals, Inc. A Takeda Oncology Company

Eligibility Criteria

Inclusion Criteria

  • \- healthy male subjects
  • \- 18 to 45 yrs, inclusive, at screening
  • \- BMI: 18\.0 to 30\.0 kg/m2, inclusive

Exclusion Criteria

  • Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials